Reportedly, determination of several phospholipids in amniotic fluid, including phosphatidylglycerol and phosphatidylinositol, in addition to lecithin and sphingomyelin improves prediction of neonatal pulmonary function. In this study, we evaluated a two-dimensional technique for separating and measuring these phospholipids and compared it with a simpler one-dimensional procedure. The two-dimensional technique was adapted to readily available commercial plates, and a preheating step was introduced to avoid shattering of the plates during charring. 
phospholipids
Over the years, various methods have been proposed for assessing fetal lung maturity by analyzing amniotic fluid (AF).1 One of these, evaluation of the lecithin/sphingomyelin (L/S) ratio, is widely used as the clinical test for predicting the respiratory distress syndrome (1) . A "mature" L/S ratio appears to be very reliable in predicting fetal lung maturity, but false-positive results do occur (2) . The L/S ratio has been less reliable in predicting fetal lung immaturity (2, 3) . Recent studies (4) (8) . Others used a one-dimensional procedure in which two different solvent systems were used successively (9) . Other, more recent one-dimensional techniques have been adapted to use in separating phospholipids in AF, but thus far none of them gives complete resolution of PS and P1 or PS and PE (10) (11) (12) .
Our purpose in this study was to determine which of two techniques for separating AF phospholipids would be the more appropriate for routine use in the clinical laboratory, the two-dimensional technique of Haliman et al. (6) or a onedimensional procedure similar to that reported by Tsai and Marshall (11) . We slightly modified the technique of Hailman et al. (6) so that commercially available thin-layer chromatographic plates could be used.
Materials and Methods

Samples:
We studied AF samples from 59 patients who required amniocentesis.
Of these, 32 had previously had Cesarean sections, 10 had diabetes mellitus, six were Rh negative and sensitized, six had pre-eclampsia, and five had chronic hypertension.
The mean gestational age was 39 (SD 2.2) weeks. We assayed a single sample from each patient.
In studying the correlation between these two techniques, we used amniotic fluid that was uncontaminated with blood or meconium, but we also studied the effect of such contamination. The fluids contaminated with blood contained no more than 3 mL of blood per deciliter.
Method: Fluids were centrifuged at 1000 X g for 5 mm and the supernatant fluid was analyzed within 2 h or stored frozen until analysis. Phospholipids were extracted by use of the method of Gluck et al. (1) . After extraction, the lipid residue was dissolved in 20 iiL of chloroform.
The sample was then divided and analyzed by both the one-and the two-dimensional techniques. The volume of lipid extract applied to the plate ranged from 5 to 10 sL, depending on a visual estimate of the amount of dried lipid present after the precipitation with acetone. Commercially available thin-layer chromatographic plates, prepared with 50 g/L ammonium sulfate, 20 X 20cm, with a 200-sm coating of silica gel H (Analtech, Inc., Newark, DE 19711) were used for both techniques. We chose these plates because they are made to the specifications of the plates in the widely used two-dimensional procedure of Gluck
Thin-layer chromatography:
For the two-dimensional separation, we altered the solvent system described by Gluck et al. (personal communication) slightly, because it did not give a clear separation with the commercial plates. The PE/PS spotcontains a third component shown as an unknown (Link) In Figure   1 . PGand P1 standardsare also shown min before the second solvent system was used. Before each migration step, the plates were allowed to cool until they were just warm to the touch.
In the one-dimensional technique, the solvent system used was the same as the first in the two-dimensional procedure, and the solvent was allowed to ascend 12 cm from the origin. After development, the plates from both the one-and twodimensional procedures were preheated in an oven set at 110 #{176}C, then charred on a hot plate at 280 #{176}C for 10 mm to make the compounds visible. Initially, we used standards to assure proper identification: synthetic dipalmitoyl lecithin, bovine brain sphingomyelin and phosphatidylserine, egg-yolk phosphatidylglycerol and phosphatidylethanolammne, and soybean phosphatidylinositol (all from Sigma Chemical Co., St. Louis MO 63173). The concentration of all standards used was 1 g/L.
To obtain semi-quantitative results for each phoepholipid, the L, S, PG, P1, PE, and PS spots were scanned with a transmission densitometer in dual-beam mode with attached linear recorder and integrator (Kontes Co., Vineland, NJ, 08360). The figures for the densitometric scans of L, PG, P1, PE, and PS were totaled and each compound was expressed as a percentage of the total. On the one-dimension plate, the combined peak of PE and PS was expressed as a single value.
The one-and two-dimensional plates from each AF sample were first compared visually. The correlation between the two techniques was evaluated quantitatively by comparing the results for each compound in the 59 amniotic fluid samples. Finally, the precision of both techniques was assessed by calculating the coefficients of variation for each compound, based on 10 replicate determinations of one AF sample.
Results
Separation of phospholipids.
The two-dimensional technique gave complete resolution of L, S, PG, P1, PE, and PS.
The one-dimensional technique gave complete separation of L, S, PG, and P1, but not of PE and PS. The Rf values (mean ±SD for 10 samples) for each phospholipid analyzed were reproducible with both techniques (Table 1) .
In visually and quantitatively comparing the one-and two-dimensional procedures, we found that the latter technique gave clear resolution of the phospholipids in all fluids analyzed.
We noted interfering compounds in the one-dimensional technique in the following four circumstances:
(a)
All fluids were found to contain a compound that co-chromatographed with PE and PS in the one-dimensional tech..
nique (Figures 1 and 2) . (b) In the one-dimensional system, meconium was found to contain various compounds that cochromatographed with either L, S, P1, or PE, and often totally obscured the L/S ratio, as illustrated by AF no.1 in Figure 3A and B). (c) In some cases, blood-contaminated AF contained compounds that migrated near the PG spot in the tmi-dimension system, as shown in AF no.2 ( Figure 3A 
and C). (d)
On one occasion a non-bloody AF appeared to have PG on the one-dimensional plate, when there was clearly none in the two-dimensional ( Figure 4A and B) . Both of these last two circumstances could obscure the detection of and possibly cause a false-positive for PG.
The ease of detecting the phospholipid spots visually and PG to be present quantitating them with a densitometer varied with the two techniques. With the two-dimensional method, the phospholipid spots were easier to detect and quantitate;
with the one-dimensional technique the PG spot was diffuse, and therefore difficult to quantitate.
Precision. The precision for each technique was evaluated by determining the reproducibility of both procedures. Table   2 shows the mean, standard deviation, and coefficient of variation for 10 replicate determinations.
The standard deviation and coefficient of variation of PG was greater with the one-dimensional technique than with the two-dimensional system. The other compounds either varied similarly (L/S, L, and P1) or were impossible to compare (PE and PS).
Correlation of two techniques.
Correlation of the individual components as determined by the two techniques yielded the following r values for the 59 AF samples: L/S = 0.88, L% = 0.41, PG% = 0.84, P1% = 0.86 (all p <0.01), and (PE + PS)% = 0.35, p <0.05. In the one-dimensional method the combined PE and PS spot actually contains a third, unknown component (Figures 1 and 2 ). The correlation was weakest when the densitometric scan of the combined PE, PS, and unknown spot on the one-dimensional plates was compared with the sum of the densitometric scans of the individual PE and PS spots on the two-dimensional plates.
Assay time was 90 min for the one-dimensional method, 150 mm for the two-dimensional technique.
Discussion
The two-dimensional procedure reliably separated all phospholipid components, as previously described (6) . Although the one-dimensional procedure adequately separated the components most important clinically (L/S, PG, and P1), it presented several problems. We conclude that the twodimensional technique is the better and more appropriate technique for use in the clinical laboratory, because of potential interference by other compounds co-chromatographing with the important phospholipids in the single-dimensional procedure. Others (11) have reported that, in this technique, blood and meconium can obscure the L and S spots, a finding we confirm. Moreover, meconium may also obscure the PT,PE, or PS spots, and blood-stained AF on occasion contains compounds that can obscure PG or cause a falsely positive PG spot. The latter finding is not in agreement with a previous report of a single-dimension technique (11) . Finally, on one occasion an immature, non-bloody AF appeared to contain PG on the one-dimensional plate, but PG was clearly absent in the two-dimensional. Interference from compounds other than the phospholipids of interest could lead to inappropriate clinical decisions in diagnosing fetal maturity, and this may explain a finding reported by Cunningham et al. (13) . These investigators combined chromatography on a diethylaminocellulose column with one-dimensional thin-layer chromatography to separate AF phospholipids and reported abovenormal PG in AF from normal and diabetic pregnancies of less than 33 weeks' gestation. Their one-dimension thin-layer chromatographic step appears similar to ours and the falsepositive PG spot we occasionally saw with the one-dimension technique could account for the apparently above-normal PG that they observed in premature patients. Finally, the combined PE and PS spot described in a one-dimensional procedure by Tsai and Marshall (11) actually contains another interfering compound, previously identified by Gray (5) as lysobisphosphatidic acid. It is apparent when the one-dimensional plate pattern is compared with the two-dimensional Several important technical considerations need mention. Commercially available thin-layer chromatographic plates can be used, but the solvent ratios modified as described are required for good separation. Also after activation, the plates should be allowed to cool until they are just warm to the touch, before they are placed in the first tank, otherwise lecithin and sphingomyelin and PT and PE are poorly separated. Others (10) have found commercial thin-layer chromatographic plates unacceptable for high-temperature charring because of a tendency to shatter. We avoid this by pre-heating the plates to 110 #{176}C in an oven prior to placing them on the 280 #{176}C hot plate. inorganic phosphorus, it was low as compared with reference intervals in standard clinical chemistry textbooks. Furthermore, the results from the survey programs of the College of American Pathologists (CAP) showed that the mean result for inorganic phosphorus as determined with SMAC5 was significantly lower than that for most other analytical systems. In an attempt to resolve this apparent discrepancy, we analyzed patients' specimens, using four different analytical systems (SMAC, Technicon AutoAnalyzer, ace, and manual Fiske-SubbaRow), and also performed analytical recovery studies.
Materials and Methods
Analytical systems.
The classical manual Fiske-SubbaRow method was performed, in which phosphate reacts with ammonium molybdate to form ammonium phosphomolybdate, which is reduced with aminonaphthol sulfonic acid to produce a blue color (1) . Absorbance is measured spectrophotometrically at 650 nm. The method used with the AutoAnalyzer is the reference method that Technicon recommends, and they use it in assigning values to their SMAC calibration material (2, 3) . It is similar to the Fiske-SubbaRow method, except that stannous chloride is used as the reducing agent and the colored complex is determined at 660 nm (2) . With the Automatic Clinical Analyzer (ace; Dupont Co., Instrument Products Division, Wilmington, DE 19898) the phosphorus method involves the use of p-methylaminophenol sulfate and bisulfite to reduce the phosphomolybdate complex, which is then measured at 340 nm. The phosphorus method used in the SMAC differs significantly in that the unreduced phosphomolybdate complex, which also absorbs ultraviolet light, is determined at 340 nm (4).
Calibration materials and standards.
The Fiske-SubbaRow and AutoAnalyzer systems were standardized for phosphorus with National Bureau of Standards monobasic potassium phosphate (SRM-186-Ic KH2PO4). We calibrated the SMAC with SMAC Reference I (Technicon product no. T03-7120) and the ace with DuPont calibration materials (lots E0613A and J0669A).
Study design and statistical analyses.
To compare the results obtained on clinical samples, we analyzed 25 patients' sera on the SMAC and in triplicate by both the AutoAnalyzer and the Fiske-SubbaRow methods. Results from the SMAC were also compared with those from the aca for sera from blood samples obtained from 354 NIH employees after a short fast. The paired-sample Student's t-test was used to compare SMAC results to those of the other methods. Recovery studies were done by adding 0.2 mL of aqueous KH2PO4 (NBS SRM 186-Ic) or water to 1.8 mL of pooled serum to obtain a series of solutions with known differences in phosphorus concentration. These six solutions, covering a range of 80 mgfL, were analyzed in triplicate by each of three
